Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NL-OMON22091
NL-OMON22091CompletedNot Applicable

‘Effect of fecal transplant harvested from bariatric surgery subjects on lipid and glucose metabolism in subjects with metabolic syndrome; the FEBALIGO trial

AMC-UvA0 sites44 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
44
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

/A

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • •Male obese treatment naieve subjects with metabolic syndrome (n=22, 21 to 65 years-old; with metabolic syndrome
  • •Able to give informed consent.

Exclusion Criteria

  • •history of cardiovascular event (MI or pacemaker implantation)
  • •cholecystectomy,
  • •use of medication including PPI and antibiotics past three months,
  • •(expected) prolonged compromised immunity (due to recent cytotoxic chemotherapy or HIV infection with a CD4 count < 240).

Investigators

Sponsor
AMC-UvA

Similar Trials

Completed
Not Applicable
Effect of Fecal transplant harvested from Bariatric surgery subjects on Lipid and Glucose metabolism in subjects with metabolic syndrome;Metabolic syndrome obesity and type 2 diabetes100274241001842410013317
NL-OMON38792Academisch Medisch Centrum33
Completed
Not Applicable
Effect of Fecal Transplantation on Satiety, Sarcopenia, Inflammation and Chemotherapy Toxicity in patients with Metastasized Oesophageal and Gastric Cancer.Anorexia en sarcopenia1000301810028302
NL-OMON43382Academisch Medisch Centrum16
Completed
Not Applicable
Effect of fecal transplantation on satiety and energy metabolism in female patients with anorexIa nervosa;Anorexia and satiety1000301810014067
NL-OMON46839Academisch Medisch Centrum24
Completed
Phase 3
Implications of Fecal Microbiota Transplantation in Modulating the Effects of Liver CirrhosisLiver Cirrhosis
NCT06478602Cristian Ichim19
Recruiting
Not Applicable
‘Effect of Faecal Transplantation on Satiety, Sarcopenia, Inflammation and Chemotherapy Toxicity in patients with Metastasized Oesophageal and Gastric Cancer’patients with metastasized or locally advanced oesophageal or gastric cancer receiving standard first-line palliative chemotherapy (capecitabine/oxaliplatin).FMTmicrobiota
NL-OMON27424AMC16